This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.
Each patient (32 patients) and healthy individual (32 healthy individuals) undergoes one study visit. After providing informed consent, each patient and healthy individual receives an assessment of their retinal vessels using OCTA and SLDF. In the sub-study of 10 patients with cardiovascular disease, the reliability of the OCTA measurements will be determined. Each patient will receive three study visits (with an OCTA and SLDF assessment on each occasion) on three different days.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
64
Assessment of retinal capillary density using OCTA and SLDF
University of Erlangen Nuremberg
Erlangen, Bavaria, Germany
RECRUITINGAssessment of reliability of OCTA based assessment of retinal capillary density in patients with CV disease
Assessment of test-retest-reliability between 3 study visits for OCTA based assessment of retinal capillary density in patients with CV disease
Time frame: test-retest-reliability between 3 study visits (between each visit needs to be a time gap of at least 24 hours, all visits will be performed within two weeks)
comparison of OCTA based retinal capillary density between CV diseased patients and healthy controls
comparison of OCTA based retinal capillary density between CV diseased patients and healthy controls
Time frame: one study visit in each group, baseline values at day 1 are compared
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.